Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy

Fig. 3

Urinary C9/Cr and FGG/Cr levels in different groups (mean with 95% CI). (A) uC9/Cr levels according to T-scores. (B) uFGG/Cr levels according to T-scores in different groups. (C) uFGG/Cr levels according to T-scores in IgAN patients and healthy controls. (D) uFGG/Cr levels according to T-scores in disease controls and healthy controls. (E) FGG mRNA expression in tubulointerstitium from kidney biopsy of IgAN patients (GSE104954). ROC curves of uFGG/Cr for the discrimination of different groups in IgAN patients between: (F) fibrosis ≤ 5% vs. fibrosis > 5%, (G) T0 vs. T1 + 2, (H) T0 + 1 vs. T2. (I) ROC curves of uFGG/Cr for the discrimination of fibrosis ≤ 5% vs. fibrosis > 5% in disease control patients

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us